Ranitidine-N,S-dioxide, identified by its CAS number 1185237-42-6, is a derivative of ranitidine, a well-known histamine H2-receptor antagonist used primarily to reduce stomach acid production. This compound features a unique N,S-dioxide functional group, which may influence its pharmacological properties and metabolic pathways. Typically, compounds like ranitidine exhibit characteristics such as moderate solubility in water and organic solvents, and they may possess a range of biological activities. The presence of the N,S-dioxide moiety can enhance the compound's stability and alter its interaction with biological targets. Ranitidine itself has been widely used in the treatment of conditions like peptic ulcers and gastroesophageal reflux disease (GERD). However, it is important to note that ranitidine has faced scrutiny due to concerns about impurities linked to potential carcinogenic effects, leading to market withdrawals. The specific characteristics of ranitidine-N,S-dioxide, including its efficacy, safety profile, and potential therapeutic applications, would require further investigation through experimental studies and clinical trials.

Ranitidine-N,S-dioxide

1185237-42-6: Ranitidine-N,S-dioxide, identified by its CAS number 1185237-42-6, is a derivative of ranitidine, a well-known histamine H2-receptor antagonist used primarily to reduce stomach acid production. This compound features a unique N,S-dioxide functional group, which may influence its pharmacological properties and metabolic pathways. Typically, compounds like ranitidine exhibit characteristics such as moderate solubility in water and organic solvents, and they may possess a range of biological activities. The presence of the N,S-dioxide moiety can enhance the compound's stability and alter its interaction with biological targets. Ranitidine itself has been widely used in the treatment of conditions like peptic ulcers and gastroesophageal reflux disease (GERD). However, it is important to note that ranitidine has faced scrutiny due to concerns about impurities linked to potential carcinogenic effects, leading to market withdrawals. The specific characteristics of ranitidine-N,S-dioxide, including its efficacy, safety profile, and potential therapeutic applications, would require further investigation through experimental studies and clinical trials.

<p>Stability Hygroscopic<br>Applications Ranitidine N,S-Dioxide is a possible metabolite of Ranitidine (R120000).<br></p>

CAS 1185237-42-6

Ranitidine-N,S-dioxide

Ranitidine N,S-Dioxide

Ref: TR-R120020